Class information for:
Level 1: VORICONAZOLE//HYDROXYITRACONAZOLE//POSACONAZOLE

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
9595 1073 33.3 82%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)



ID, lev.
above
Publications Label for level above
80 26597 ASPERGILLOSIS//VORICONAZOLE//AMPHOTERICIN B

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 VORICONAZOLE Author keyword 76 26% 24% 255
2 HYDROXYITRACONAZOLE Author keyword 48 91% 2% 20
3 POSACONAZOLE Author keyword 43 32% 11% 113
4 ITRACONAZOLE Author keyword 16 11% 13% 135
5 SCH 56592 Author keyword 11 100% 1% 6
6 GLOBAL ESTABLISHED PHARMA BUSINESS Address 6 80% 0% 4
7 PFIZER CLIN UNIT Address 6 47% 1% 9
8 HYDROXY ITRACONAZOLE Author keyword 4 75% 0% 3
9 CAS 84625 61 6 Author keyword 2 67% 0% 2
10 ITRACONAZOLE SOLUTION Author keyword 2 67% 0% 2

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 VORICONAZOLE 76 26% 24% 255 Search VORICONAZOLE Search VORICONAZOLE
2 HYDROXYITRACONAZOLE 48 91% 2% 20 Search HYDROXYITRACONAZOLE Search HYDROXYITRACONAZOLE
3 POSACONAZOLE 43 32% 11% 113 Search POSACONAZOLE Search POSACONAZOLE
4 ITRACONAZOLE 16 11% 13% 135 Search ITRACONAZOLE Search ITRACONAZOLE
5 SCH 56592 11 100% 1% 6 Search SCH+56592 Search SCH+56592
6 HYDROXY ITRACONAZOLE 4 75% 0% 3 Search HYDROXY+ITRACONAZOLE Search HYDROXY+ITRACONAZOLE
7 CAS 84625 61 6 2 67% 0% 2 Search CAS+84625+61+6 Search CAS+84625+61+6
8 ITRACONAZOLE SOLUTION 2 67% 0% 2 Search ITRACONAZOLE+SOLUTION Search ITRACONAZOLE+SOLUTION
9 SBECD 2 67% 0% 2 Search SBECD Search SBECD
10 SYSTEMIC ANTIFUNGAL DRUGS 2 67% 0% 2 Search SYSTEMIC+ANTIFUNGAL+DRUGS Search SYSTEMIC+ANTIFUNGAL+DRUGS

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ORAL POSACONAZOLE 81 80% 5% 51
2 HYDROXYITRACONAZOLE 67 89% 3% 31
3 UK 109 496 48 61% 5% 51
4 INTRAVENOUS VORICONAZOLE 34 79% 2% 22
5 TRIAZOLE ANTIFUNGAL AGENT 28 56% 3% 34
6 EXPOSURE RESPONSE RELATIONSHIP 27 76% 2% 19
7 SCH 56592 18 38% 4% 38
8 TO ORAL SWITCH 15 88% 1% 7
9 CELL TRANSPLANT RECIPIENTS 11 13% 8% 83
10 HYDROXY METABOLITE 10 63% 1% 10

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Voriconazole phototoxicity in children: A retrospective review 2015 2 23 70%
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology 2014 22 124 71%
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications 2009 167 79 57%
Voriconazole-Associated Cutaneous Malignancy: A Literature Review on Photocarcinogenesis in Organ Transplant Recipients 2014 13 30 57%
Therapeutic Drug Monitoring of Voriconazole and Posaconazole 2011 27 34 88%
Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring 2012 35 55 78%
Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis 2013 13 67 70%
Triazole Antifungal Agents in Invasive Fungal Infections A Comparative Review 2011 37 97 47%
Voriconazole: A new triazole antifungal agent 2003 334 37 51%
Optimizing antifungal choice and administration 2013 15 68 50%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ.
in class
1 GLOBAL ESTABLISHED PHARMA BUSINESS 6 80% 0.4% 4
2 PFIZER CLIN UNIT 6 47% 0.8% 9
3 SECT INFECT DIS MED MICROBIOL IMMUNOL 2 67% 0.2% 2
4 MICROBIOL CLIN INFECT DIS 2 43% 0.3% 3
5 HOME CANC CARE SERV 1 100% 0.2% 2
6 NEW S WALES REFERRAL THER EUT DRUG MONITORIN 1 100% 0.2% 2
7 BMBF 01KN0706 1 30% 0.3% 3
8 CANC NEUROSCI 1 33% 0.2% 2
9 EARLY CLIN EXPT MED 1 23% 0.3% 3
10 AFDELING ALGEMENE INWENDIGE GENEESKUNDE 1 50% 0.1% 1

Related classes at same level (level 1)



Rank Relatedness score Related classes
1 0.0000229280 CYP51A//ISAVUCONAZOLE//AZOLE RESISTANCE
2 0.0000209529 FLUCONAZOLE//FOSFLUCONAZOLE//MICRODILUTION TEST
3 0.0000206639 ASPERGILLOSIS//INVASIVE ASPERGILLOSIS//INVASIVE PULMONARY ASPERGILLOSIS
4 0.0000121099 OPTICALLY ACTIVE ANTIFUNGAL AZOLE//BIOORGAN MED CHEM//CS 758
5 0.0000120370 CANDIDEMIA//CANDIDAEMIA//ANIDULAFUNGIN
6 0.0000106342 SCEDOSPORIUM APIOSPERMUM//PSEUDALLESCHERIA BOYDII//SCEDOSPORIUM PROLIFICANS
7 0.0000096892 FUSARIOSIS//INVASIVE FUSARIOSIS//DISSEMINATED FUSARIOSIS
8 0.0000077037 TOLNAFTATE//KETOCONAZOLE DETERMINATION//PIRIBEDIL
9 0.0000072280 CYP3A//COCKTAIL//MECHANISM BASED INHIBITION
10 0.0000068330 AMPHOTERICIN B//AMPHOTERICIN B LIPID COMPLEX//AMPHOTERICIN B COLLOIDAL DISPERSION